A randomised phase 111, double blind, placebo-controlled study of Denosumab as adjuvant treatment for women with early stage breast cancer at high risk of recurrence (D-Care)

Hdl Handle:
http://hdl.handle.net/10147/142435
Title:
A randomised phase 111, double blind, placebo-controlled study of Denosumab as adjuvant treatment for women with early stage breast cancer at high risk of recurrence (D-Care)
Issue Date:
16-Sep-2011
URI:
http://hdl.handle.net/10147/142435
Keywords:
BREAST CANCER
Local subject classification:
DENOSUMAB
Duration of Research:
Trial open to accrual.
Ethical Approval:
Yes
Start Date:
2010-10
Principal Investigator:
O'Connor, Miriam Dr.

Full metadata record

DC FieldValue Language
dc.date.accessioned2011-09-16T10:13:53Z-
dc.date.available2011-09-16T10:13:53Z-
dc.date.issued2011-09-16T10:13:53Z-
dc.identifier.urihttp://hdl.handle.net/10147/142435-
dc.subjectBREAST CANCERen
dc.subject.otherDENOSUMABen
dc.titleA randomised phase 111, double blind, placebo-controlled study of Denosumab as adjuvant treatment for women with early stage breast cancer at high risk of recurrence (D-Care)en
dc.type.qualificationlevelN/Aen
cr.durationTrial open to accrual.en
cr.approval.ethicalYesen
cr.contributor.principalO'Connor, Miriam Dr.en
cr.date.start2010-10-
dc.description.provinceMunster-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.